Cornerstone Capital Management Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,800	Closed	-$29K	–	1396
2016 Q4	$29K	Sell	21,800 -3,500	-14%	-$4.57K	﹤0.01%	1292
2016 Q3	$39K	Sell	25,300 -10,700	-30%	-$16.4K	﹤0.01%	1302
2016 Q2	$48K	Sell	36,000 -17,687	-33%	-$82.7K	﹤0.01%	1318
2016 Q1	$282K	Buy	53,687 +4,800	+10%	+$29.4K	﹤0.01%	1149
2015 Q4	$383K	Sell	48,887 -22,113	-31%	-$190K	﹤0.01%	1091
2015 Q3	$600K	Buy	71,000 +18,200	+34%	+$168K	0.01%	965
2015 Q2	$579K	Sell	52,800 -23,900	-31%	-$307K	0.01%	965
2015 Q1	$1.07M	Sell	76,700 -19,900	-21%	-$304K	0.01%	867
2014 Q4	$1.63M	Buy	+96,600	New	+$1.41M	0.02%	768
2013 Q3	–	Sell	-4,900	Closed	-$80K	–	1359
2013 Q2	$80K	Buy	+4,900	New	+$152K	﹤0.01%	1142

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Cornerstone Capital Management Holdings's INFI Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2017, closing a stake of 21,800 shares — an estimated $29K sold.

Cornerstone Capital Management Holdings first reported a position in INFI in Q2 2013 and held it in 10 quarters. The position peaked at $1.63M in Q4 2014. 80 funds tracked by Wall St. Rank hold INFI as of Q1 2017.

Cornerstone Capital Management Holdings reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 21,800 Infinity Pharmaceuticals, Inc. shares in Q1 2017, an estimated $29K.
Cornerstone Capital Management Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
Cornerstone Capital Management Holdings's Infinity Pharmaceuticals, Inc. position peaked at $1.63M in Q4 2014.
80 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.